If P2b comes in with the strong efficacy and safety results that most are expecting, should we expect IPIX to immediately file a Compassionate Use request based on the decades old safety history of the parent drug or would this not be allowed by the FDA because of many other treatments currently on the market?

Since we already have the formulation for the pill, it seems like we should be able to have someone pump them out readily and save many psoriasis sufferers the worrisome side effects of other treatments and possibly greatly enhance their lives through the great relief in itching that we expect P2b results to show are quite evident.